Gilmore O'Neill, M.B., M.M.Sc
2019
Compensation breakdown
| Non-Equity Incentive Plan | $354,063 |
|---|---|
| Option Awards | $4,234,786 |
| Salary | $563,962 |
| Other | $15,300 |
| Total | $5,168,110 |
MMSc received $4.2M in option awards, accounting for 82% of the total pay in 2019.
MMSc also received $354.1K in non-equity incentive plan, $564K in salary and $15.3K in other compensation.
Rankings
In 2019, Gilmore O'Neill, M.B., M.M.Sc's compensation ranked 2,105th out of 13,971 executives tracked by ExecPay. In other words, MMSc earned more than 84.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,105 out of 13,971 | 85th |
Division Manufacturing | 763 out of 5,698 | 87th |
Major group Chemicals And Allied Products | 235 out of 2,197 | 89th |
Industry group Drugs | 190 out of 1,883 | 90th |
Industry Pharmaceutical Preparations | 137 out of 1,395 | 90th |
Pay ratio
| Gilmore O'Neill, M.B., M.M.Sc's Pay | $5,168,110 |
|---|---|
| Median Employee's Pay | $290,714 |
| Pay Ratio | 18to 1 |
In 2019, the annual total compensation of Gilmore O'Neill, M.B., M.M.Sc was $5,168,110.
The annual total compensation of the median employee at Sarepta Therapeutics was $290,714.
The ratio of Gilmore O'Neill, M.B., M.M.Sc's pay to the pay of median employee was therefore 18 to one.
MMSc's colleagues
We found four more compensation records of executives who worked with Gilmore O'Neill, M.B., M.M.Sc at Sarepta Therapeutics in 2019.